AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Oncopeptides

Major Shareholding Notification Nov 8, 2019

3091_iss_2019-11-08_7e2087e8-4b3d-440d-8f82-28283988aa45.pdf

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

Issuer Oncopeptides AB

Holder

Handelsbanken Fonder AB

Instrument

Instrument Aktie SE0009414576
Before the transaction
Shares 2,750,000
Voting rights 2,750,000
Transaction
Reason for major shareholding notification Buy
Date 07/11/2019
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 2,797,762
Directly held voting rights 2,797,762
Indirectly held voting rights 0
Percentage
Directly held shares 5.05 %
Directly held voting rights 5.05 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 5.05 % 2,797,762
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 5.05 % 2,797,762
Group total holdings
Voting rights
2,797,762
Percentage of voting rights 5.05
Published
08/11/2019 16:18
Contact
Name
Johanna Lindlöf
Phone
08-7012058
Email [email protected]
CLOSE
PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25

Talk to a Data Expert

Have a question? We'll get back to you promptly.